RNH1, the placental ribonuclease (RNase) inhibitor, is an acidic 460-amino acid protein which contains an unusually high content of leucine and cysteine residues. It is a member of a family of proteinaceous cytoplasmic RNase inhibitors that are expressed in many tissues and bind to both intracellular and extracellular RNases in the cytosol. RNH1 binds to a diverse variety of mammalian RNases and holds them in a latent form. It is also important in the control of mRNA turnover. RNH1inhibits angiogenesis by reversibly binding angiogenin, a member of the RNaseA superfamily. Because angiogenesis is necessary for the growth and metastasis of tumors, RNH1 may play an important role in cancer gene therapy.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of RNH1 of human and, to a lesser extent, mouse and rat origin by WB, IP, IF and ELISA
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 1-135 mapping at the N-terminus of RNH1 of human origin
Tissue Specificity
epitope corresponding to amino acids 1-135 mapping at the N-terminus of RNH1 of human origin